Altered CD4 /CD8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis Altered CD4 /CD8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis2018-01-17T17:04:28-05:00
Therapeutic Considerations for Disease Progression in Multiple Sclerosis Therapeutic Considerations for Disease Progression in Multiple Sclerosis2018-01-17T17:01:30-05:00
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:00:50-05:00
